All Type of News
Bacchus D to be sold as quasi-drug
The Korea Food and Drug Administration says that Dong-A Pharmaceutical’s Bacchus-D was reclassified into one of the quasi-drugs last month, although the company has pledged to provide Bacchus-F to retailers and Bacchu...
Korea’s breast cancer prevalence highest in OECD
The nation’s prevalence of breast cancer has recently revealed a 3.5-fold increase from 1996 to 2008, showing the highest increase in OECD countries, according to the Korean Breast Cancer Society (KBCS).
According ...
HanAll initiate Phase I trial for oral formulation of human growth hormone
HanAll BioPharma Co. said Thursday it has initiate Phase I trial in Seoul National University Hospital for orally available protease resistant human growth hormone (HL-032).
This clinical study is designed to compa...
2011 welfare budget to rise 6.4%
The government has increased its welfare budget for next year by 6.4 percent from this year to 92 trillion won.
Its welfare budget amounts to 28.2 percent of total expenditure, taking the largest portion for the se...
Pharmacists concern over public antipathy
Pharmacists are perplexed by growing discontent from consumers as a bill aiming to make cold medicines and analgesics available at supermarkets and convenience stores faces strong resistance from lawmakers.
Accord...
Are drug firms’ countermeasures effective?
The domestic pharmaceutical community has vehemently protested against the government’s plan to cut drug prices by an average of 17 percent starting next year.
The chief executives of the Korea Pharmaceutical Manuf...
Korea urged to curb healthcare costs through health management programs
Korea has talented doctors and many advanced medical centers, so the country needs to promote the health management programs for more sustainable services, according to a lawmaker.
Citing the data released by the N...
Dong-A seeks overseas expansion with Zydena
Dong-A Pharmaceutical Co. is ramping up its overseas expansion drive with Zydena to make it one of the leading erectile dysfunction treatments in a global arena.
Between September 26 and 28, the company held a pro...
Drug firms tackle business uncertainties ahead of 2012
Korean pharmaceutical companies are concerned over mounting external and internal business uncertainties, which have caused them to tighten their belts on their operations.
Industry experts say that the government’...
Dong-A, Green Cross see double-digit growth in sales
The third quarter sales of Dong-A Pharmaceutical Co. and Green Cross Corp. third quarter sales are expected to increase by 16.8 percent and 25 percent, respectively, compared to the same period last year, Eugene Inves...
